Want to see SBFM full AI Analyst Report?
Sunshine Biopharma (SBFM) Q2 2026 Earnings Report
SBFM Q2 2026 EPS Results
- Actual EPS
- -$1.15
- Consensus EPS
- -$1.20
- Beat/Miss
- Beat by +$0.05
- One Year Ago EPS
- -$3.90
SBFM Q2 2026 Revenue Results
- Actual Revenue
- $9.26M
- Expected Revenue
- $8.70M
- Beat/Miss
- Beat by +$563.69K
- YoY Revenue Growth
- -1.56%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/05/2026
- Time
- TBA
- Conference Call
- Wednesday, August 5, 2026
SBFM Upcoming Earnings
Sunshine Biopharma's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
SBFM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -3.40- | -38 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | -1.20-1.15 | -3.9 | 70.51% (+2.75) | |
| May 14, 2026 | 2026 (Q1) | -32.00-50.00 | -88 | 43.18% (+38.00) | |
| Nov 11, 2025 | 2025 (Q3) | -1.30-1.90 | -9.4 | 79.79% (+7.50) | |
| Jul 30, 2025 | 2025 (Q2) | -0.11-0.39 | -9.94 | 96.04% (+9.55) | |
| May 15, 2025 | 2025 (Q1) | ―-88.00 | -8000 | 98.90% (+7912.00) | |
| Apr 08, 2025 | 2024 (Q4) | 0.01-0.84 | -40 | 97.91% (+39.16) | |
| Nov 06, 2024 | 2024 (Q3) | -107000.00-188.00 | -16000 | 98.83% (+15812.00) | |
| Aug 19, 2024 | 2024 (Q2) | -120.00-1988.00 | -8000 | 75.15% (+6012.00) | |
| May 08, 2024 | 2024 (Q1) | ―- | -0.08 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
